アラクス健康プラス　大豆イソフラボン: notification withdrawn

Registration number

B164

Type

Processed food (tablets, capsules and similar forms)

Published status

Notification withdrawn

Notifier

株式会社アラクス

Notification date

2016-08-22

Modification date

2019-08-20

Withdrawal date

2024-10-04

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

• Conditions légales

  Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Information

  A claim declared in Japan is not an authorised health claim in the European Union.

  CAA, Japan Foods with Function Claims notifications, retrieved 27 October 2026.

  Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

  Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

大豆イソフラボン含有加工食品

Declared claim (original Japanese text)

本品には大豆イソフラボンが含まれます。大豆イソフラボンは骨の成分の維持に役立つことが報告されており、丈夫な骨を維持したい中高年女性に適しています。

Precautions (original Japanese text)

妊娠中の方、授乳中の方、乳幼児及び小児は摂取しないでください。イソフラボンを含む特定保健用食品等との併用は避け、過剰摂取はしないでください。

Reason for withdrawal (original Japanese text)

販売予定がないため

Raw materials of functional ingredients (original Japanese text)

大豆胚芽エキス末

Recommended daily intake (original Japanese text)

4粒

Method of consumption (original Japanese text)

水などと一緒にお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

大豆イソフラボン

Declared daily quantities (original Japanese text)

25mg（アグリコン換算）

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

Official source

View the official register, number B164

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated 20 August 2019 (register: CAA, Japan Foods with Function Claims notifications).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging